| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/29/2004 | US20040146485 Vaccines including as an adjuvant type 1 ifn and process related thereto |
| 07/29/2004 | US20040146479 Washing hands with first composition for removal of any anionic species which reduce the bactericidal efficacy of biocides, ensuring that no composition containing an anionic surfactant contacts the skin after step (1) |
| 07/29/2004 | US20040146468 With excipient; suppress or reduce the gustatory function, in particular as regards a bitter and/or sweet and/or acid taste |
| 07/29/2004 | DE10303671A1 New 8alpha,14beta-dialkyl-18-nor steroids useful as pharmaceuticals, intermediates or carriers for treating e.g. tumors, alzheimers disease |
| 07/29/2004 | DE10302421A1 New double-stranded interfering RNA, useful for inhibiting hepatitis C virus, has one strand linked to a lipophilic group to improve activity and eliminate the need for transfection auxiliaries |
| 07/29/2004 | CA2512908A1 A method of treatment or prophylaxis of symptoms of herpes viral infection |
| 07/29/2004 | CA2512812A1 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 07/29/2004 | CA2512673A1 2-o sulfatase compositions and related methods |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |
| 07/28/2004 | EP1440982A2 Ifn-thy fusion protein, dna coding therefore, its preparation and application |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440167A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319 |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440149A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440087A2 Mycobacterial genes down-regulated during latency |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440072A2 Purine analogs having hsp90-inhibiting activity |
| 07/28/2004 | EP1440070A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440069A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440068A1 Acyl dihydro pyrrole derivatives as hcv inhibitors |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP1439878A2 Method and apparatus for dispensing inhalator medicament |
| 07/28/2004 | EP1439853A2 Means for inhibition of lentiviruses |
| 07/28/2004 | EP1439845A1 Inactivation of papillomavirus |
| 07/28/2004 | EP1439844A1 Pharmaceutical preparation comprising a growth factor and/or a cytokine and an antiseptic biguanide |
| 07/28/2004 | EP1439843A2 Tetracycline derivatives and methods of use thereof |
| 07/28/2004 | EP1439840A1 Monobactam antibacterial compounds and methods of use thereof |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439833A1 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 07/28/2004 | EP1439826A1 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 07/28/2004 | EP1401473A4 Transporters comprising spaced arginine moieties |
| 07/28/2004 | EP1372659B1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 07/28/2004 | EP1267858B1 Diphenyl ketoaldehyde derivatives with anti-hiv activity |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1186654B1 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 narine aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof |
| 07/28/2004 | EP1176958B1 Novel catechols as antimicrobial agents |
| 07/28/2004 | EP1137632B1 Thiourea inhibitors of herpes viruses |
| 07/28/2004 | EP1028739B1 Use of protein h as cytostatic agent |
| 07/28/2004 | EP0938335B1 In ovo vaccination against newcastle disease |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0696201B1 Supplemented tissue sealants, methods of their production and use |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516738A Acetylation of GP41 framgnets |
| 07/28/2004 | CN1516735A Method to generate non-virulent microorganism from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516695A Arylsulfonamides as antiviral agents |
| 07/28/2004 | CN1516692A Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516599A Method for joint treatment of chronic hepatitis C infection using ribavirin-polyvinyl glycol interferon alpha |
| 07/28/2004 | CN1516598A Antimicrobial peptides |
| 07/28/2004 | CN1516596A Method of modulating activity of calcium channels in cardiac cells and reagents therefor |
| 07/28/2004 | CN1516590A 4'-substituted nucleosides |
| 07/28/2004 | CN1516582A 抗病毒化合物 Antiviral compounds |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1516577A Controllable released type milk duct suppository |
| 07/28/2004 | CN1515678A Preparation method of natamycin |
| 07/28/2004 | CN1515674A Biological pure culture for Nocardia |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515667A Livstock mucosal competitive exclusion culture for reducing enteropathogenic bacteria |
| 07/28/2004 | CN1515590A Erythropoietin conjugate |
| 07/28/2004 | CN1515574A Substituted 7-acylamino-3-(methyldiazanediyl) methylcephalosporin and intermediate body with antibiotic action |
| 07/28/2004 | CN1515572A Carbocyclic nucleoside semi-sulfate and its application for curing viral infection |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
| 07/28/2004 | CN1515308A Chinese patent medicine for curing chronix virus B hepatitis and its preparation method |
| 07/28/2004 | CN1515304A Specific Chinese medicine preparation for curing pneumocoiosis and tuberculosis |
| 07/28/2004 | CN1515301A Medicine for curing upper respiratory tract infection and preparation method of its granule preparation |
| 07/28/2004 | CN1515298A Preparation method of pentaester granules |
| 07/28/2004 | CN1515295A Astragalus root extract injection and its preparation method |
| 07/28/2004 | CN1515292A Tenderizing and detoxicating health-care cold tea and its preparation method |
| 07/28/2004 | CN1515283A Chinese patent medicine prescription composition for curing pulmonary tuberculosis an dits preparation method |
| 07/28/2004 | CN1515277A Method for extractings ubstance resisting respiratory syncytial virus from patrinia |
| 07/28/2004 | CN1515275A Chinese medicine composition with action of nourishing lung, curing cough and relieving asthma |
| 07/28/2004 | CN1515269A Application of ivory powder for curing bone tuberculosis and osteomyelitis |
| 07/28/2004 | CN1515262A Adfuwei ester enteric soluble preparation |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1515250A New houttuynin sodium injection preparation and its preparation method |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1515245A Vaccine containing saponin and sterol |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159441C USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 07/28/2004 | CN1159332C Thiophosphoryl amino acid ester compound and its prepn process |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/28/2004 | CN1159313C Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 07/28/2004 | CN1159311C Dihydropyrimidines |
| 07/28/2004 | CN1159303C Preparation of intermediate for monocyclic beta-lactams antibiotic derivatives |
| 07/28/2004 | CN1159064C Group A streptococcal polysaccharide immunogenic compositions and methods |
| 07/28/2004 | CN1159060C Application of bicoptis for injection in preparation of medicine for curing serious acute respiratory tract syndrome |
| 07/28/2004 | CN1159057C Medicine for treating hepatitis, and preparing process thereof |
| 07/28/2004 | CN1159055C Medicine for treating beriberi and its preparing process |
| 07/28/2004 | CN1159035C Antitetanic medicine and preparation method thereof |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159011C 苦参碱阴道凝胶 Matrine vaginal gel |
| 07/28/2004 | CN1159008C Concentrated granular medicine for treating baby cold and preparation preocess thereof |